Literature DB >> 22134129

Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Luis D Medina1, Yaneth Rodriguez-Agudelo, Daniel H Geschwind, Paul E Gilbert, Li-Jung Liang, Jeffrey L Cummings, John M Ringman.   

Abstract

BACKGROUND/AIMS: A relationship between decreased propositional density (p-density) in young adulthood and future risk for Alzheimer's disease (AD) has been postulated, but multiple interpretations of the nature of this relationship are possible. This study explored the relationship between familial AD (FAD) mutation status, apolipoprotein E (APOE) genotype, and p-density.
METHODS: Thirty-five non-demented persons at risk for FAD mutations were recruited. Subjects wrote brief biographical essays from which p-density, the ratio of the number of unique ideas to the number of words in the text, was calculated. mixed-effects regression models were used to examine the relationship of p-density and fad mutation status and apoe genotype.
RESULTS: FAD mutation status was not significantly associated with p-density. However, results from both models indicated that the presence of the APOE ε4 allele was significantly associated with p-density (p < 0.0001), with APOE ε4 carriers having lower p-density than non-carriers.
CONCLUSIONS: Our results are consistent with an influence of APOE status on p-density in young adulthood that is independent of the AD risk per se and suggest the previous finding of increased risk for the development of AD in persons with decreased p-density may be related to APOE genotype.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134129      PMCID: PMC3542946          DOI: 10.1159/000333023

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

1.  Relation of age and apolipoprotein E to cognitive function in Down syndrome adults.

Authors:  G E Alexander; A M Saunders; J Szczepanik; T L Strassburger; P Pietrini; A Dani; M L Furey; M J Mentis; A D Roses; S I Rapoport; M B Schapiro
Journal:  Neuroreport       Date:  1997-05-27       Impact factor: 1.837

2.  Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.

Authors:  Karen J Miller; Steven A Rogers; Prabha Siddarth; Gary W Small
Journal:  Int J Geriatr Psychiatry       Date:  2005-02       Impact factor: 3.485

Review 3.  What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review.

Authors:  John M Ringman
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

4.  2011 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2011-03       Impact factor: 21.566

5.  Language decline across the life span: findings from the Nun Study.

Authors:  S Kemper; L H Greiner; J G Marquis; K Prenovost; T L Mitzner
Journal:  Psychol Aging       Date:  2001-06

6.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

7.  Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; Mark F Desrosiers; William R Markesbery
Journal:  Neurobiol Aging       Date:  2005-03       Impact factor: 4.673

8.  Healthy aging and dementia: findings from the Nun Study.

Authors:  David A Snowdon
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

9.  The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia.

Authors:  E L Teng; K Hasegawa; A Homma; Y Imai; E Larson; A Graves; K Sugimoto; T Yamaguchi; H Sasaki; D Chiu
Journal:  Int Psychogeriatr       Date:  1994       Impact factor: 3.878

10.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study.

Authors:  D A Snowdon; S J Kemper; J A Mortimer; L H Greiner; D R Wekstein; W R Markesbery
Journal:  JAMA       Date:  1996-02-21       Impact factor: 56.272

View more
  5 in total

1.  Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.

Authors:  Kimberly Diggle Mueller; Rebecca L Koscik; Lyn S Turkstra; Sarah K Riedeman; Asenath LaRue; Lindsay R Clark; Bruce Hermann; Mark A Sager; Sterling C Johnson
Journal:  J Alzheimers Dis       Date:  2016-10-18       Impact factor: 4.472

2.  Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.

Authors:  Sid E O'Bryant; Leigh Johnson; Valerie Balldin; Melissa Edwards; Robert Barber; Benjamin Williams; Michael Devous; Blair Cushings; Janice Knebl; James Hall
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Olfactory dysfunction in the 3xTg-AD model of Alzheimer's disease.

Authors:  Darlene A Mitrano; Sam E Houle; Patrick Pearce; Ricardo M Quintanilla; Blakely K Lockhart; Benjamin C Genovese; Rachel A Schendzielos; Emma E Croushore; Ethan M Dymond; James W Bogenpohl; Harold J Grau; Lisa Smith Webb
Journal:  IBRO Neurosci Rep       Date:  2021-01-08

4.  PSEN1 c.1292C<A Variant and Early-Onset Alzheimer's Disease: A Scoping Review.

Authors:  Maribel Orozco-Barajas; Yulisa Oropeza-Ruvalcaba; Alejandro A Canales-Aguirre; Victor J Sánchez-González
Journal:  Front Aging Neurosci       Date:  2022-07-22       Impact factor: 5.702

5.  Asymmetric left-right hippocampal glutamatergic modulation of cognitive control in ApoE-isoform subjects is unrelated to neuroinflammation.

Authors:  Hui Zhang; Pui Wai Chiu; Isaac Ip; Tianyin Liu; Gloria Hoi Yan Wong; You-Qiang Song; Savio Wai Ho Wong; Karl Herrup; Henry Ka Fung Mak
Journal:  Eur J Neurosci       Date:  2021-08-02       Impact factor: 3.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.